18F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer.
Mesci A, Ahmadi E, Ali A, Gouran-Savadkoohi M, Evelyn Tsakiridis E, Biziotis OD, Chow T, Kapoor A, Sur M, Steinberg GR, Liu S, Zukotynski K, Tsakiridis T.
Mesci A, et al. Among authors: gouran savadkoohi m.
Clin Transl Radiat Oncol. 2023 Jan 18;39:100583. doi: 10.1016/j.ctro.2023.100583. eCollection 2023 Mar.
Clin Transl Radiat Oncol. 2023.
PMID: 36713978
Free PMC article.